- Home
- POOL vs IKT Comparison
POOL vs IKT Comparison
Compare POOL & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POOL
- IKT
- Stock Information
- Founded
- POOL 1993
- IKT 2008
- Country
- POOL United States
- IKT United States
- Employees
- POOL N/A
- IKT N/A
- Industry
- POOL Industrial Specialties
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- POOL Consumer Discretionary
- IKT Health Care
- Exchange
- POOL Nasdaq
- IKT Nasdaq
- Market Cap
- POOL 13.8B
- IKT 159.2M
- IPO Year
- POOL 1995
- IKT 2020
- Fundamental
- Price
- POOL $349.04
- IKT $3.42
- Analyst Decision
- POOL Hold
- IKT Strong Buy
- Analyst Count
- POOL 8
- IKT 2
- Target Price
- POOL $369.25
- IKT $6.50
- AVG Volume (30 Days)
- POOL 339.0K
- IKT 450.8K
- Earning Date
- POOL 02-20-2025
- IKT 11-14-2024
- Dividend Yield
- POOL 1.38%
- IKT N/A
- EPS Growth
- POOL N/A
- IKT N/A
- EPS
- POOL 11.61
- IKT N/A
- Revenue
- POOL $5,326,524,000.00
- IKT $1.00
- Revenue This Year
- POOL N/A
- IKT N/A
- Revenue Next Year
- POOL $3.90
- IKT N/A
- P/E Ratio
- POOL $30.06
- IKT N/A
- Revenue Growth
- POOL N/A
- IKT N/A
- 52 Week Low
- POOL $293.51
- IKT $1.12
- 52 Week High
- POOL $422.73
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- POOL 38.15
- IKT 52.41
- Support Level
- POOL $340.00
- IKT $3.12
- Resistance Level
- POOL $380.82
- IKT $4.20
- Average True Range (ATR)
- POOL 8.16
- IKT 0.42
- MACD
- POOL -3.71
- IKT -0.00
- Stochastic Oscillator
- POOL 22.15
- IKT 30.67
About POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. It sells national-brand and private-label products to approximately 120000 customers. The products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.